A Randomized Trial to Study the Safety and Efficacy of EGF Cancer Vaccination in Late-stage (IIIB/IV) Non-small Cell Lung Cancer Patients
Clinical trial NCT01444118 · TERMINATED
Trial details
- NCT number
- NCT01444118
- Sponsor
- Bioven Europe
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-12-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.